These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32503668)

  • 1. Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients.
    Ma A; Cheng J; Yang J; Dong M; Liao X; Kang Y
    Crit Care; 2020 Jun; 24(1):288. PubMed ID: 32503668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
    Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
    Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
    Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
    Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study.
    Peng J; Qi D; Yuan G; Deng X; Mei Y; Feng L; Wang D
    J Clin Lab Anal; 2020 Oct; 34(10):e23475. PubMed ID: 32681559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey.
    Tzotzos SJ; Fischer B; Fischer H; Zeitlinger M
    Crit Care; 2020 Aug; 24(1):516. PubMed ID: 32825837
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive value of neutrophil to lymphocyte and platelet to lymphocyte ratio in COVID-19.
    Zhu S; Dong L; Cai W
    Crit Care; 2020 Aug; 24(1):532. PubMed ID: 32859254
    [No Abstract]   [Full Text] [Related]  

  • 8. The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS.
    Dreher M; Kersten A; Bickenbach J; Balfanz P; Hartmann B; Cornelissen C; Daher A; Stöhr R; Kleines M; Lemmen SW; Brokmann JC; Müller T; Müller-Wieland D; Marx G; Marx N
    Dtsch Arztebl Int; 2020 Apr; 117(16):271-278. PubMed ID: 32519944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome.
    Chiscano-Camón L; Ruiz-Rodriguez JC; Ruiz-Sanmartin A; Roca O; Ferrer R
    Crit Care; 2020 Aug; 24(1):522. PubMed ID: 32847620
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the Clinical Course of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome in 2 Passengers from the Cruise Ship Diamond Princess in February 2020.
    Matsumura K; Toyoda Y; Matsumoto S; Kawai Y; Mori T; Omasa K; Fukada T; Yamada M; Kazamaki T; Furugori S; Hiroe N; Senoo S; Shimizu M; Funabiki T; Yamazaki M
    Am J Case Rep; 2020 Aug; 21():e926835. PubMed ID: 32811804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness and safety of a dedicated team to prone patients with severe ARDS due to COVID-19.
    Kimmoun A; Levy B; Chenuel B;
    Crit Care; 2020 Aug; 24(1):509. PubMed ID: 32811555
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulatory T Cells Tested in Patients With COVID-19 ARDS.
    Abbasi J
    JAMA; 2020 Aug; 324(6):539. PubMed ID: 32780125
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe pulmonary embolism in COVID-19 patients: a call for increased awareness.
    Hékimian G; Lebreton G; Bréchot N; Luyt CE; Schmidt M; Combes A
    Crit Care; 2020 Jun; 24(1):274. PubMed ID: 32487231
    [No Abstract]   [Full Text] [Related]  

  • 15. Respiratory and ventilator management of COVID-19.
    Khan NA; Akhtar J
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S60-S63. PubMed ID: 32515384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of pulmonary surfactant in COVID-19 patients.
    Schousboe P; Wiese L; Heiring C; Verder H; Poorisrisak P; Verder P; Nielsen HB
    Crit Care; 2020 Sep; 24(1):552. PubMed ID: 32894160
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
    Wilson JG; Simpson LJ; Ferreira AM; Rustagi A; Roque J; Asuni A; Ranganath T; Grant PM; Subramanian A; Rosenberg-Hasson Y; Maecker HT; Holmes SP; Levitt JE; Blish CA; Rogers AJ
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32706339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early predictors for mechanical ventilation in COVID-19 patients.
    Li W; Lin F; Dai M; Chen L; Han D; Cui Y; Pan P
    Ther Adv Respir Dis; 2020; 14():1753466620963017. PubMed ID: 33054630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Ferritin is an independent risk factor for Acute Respiratory Distress Syndrome in COVID-19.
    Gandini O; Criniti A; Ballesio L; Giglio S; Galardo G; Gianni W; Santoro L; Angeloni A; Lubrano C
    J Infect; 2020 Dec; 81(6):979-997. PubMed ID: 32946917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.